(S)-3-(1'-phenyl-1'H-tetrazole-5'-sulfanyl)-1-tert-butyldiphenylsilyloxy-2-methylpropane | 953076-21-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: (S)-3-(1'-phenyl-1'H-tetrazole-5'-sulfanyl)-1-tert-butyldiphenylsilyloxy-2-methylpropane
• 英文别名: 5-{[(2S)-3-{[tert-butyl(diphenyl)silyl]oxy}-2-methylpropyl]sulfonyl}-1-phenyl-1H-tetrazole；tert-butyl-[(2S)-2-methyl-3-(1-phenyltetrazol-5-yl)sulfonylpropoxy]-diphenylsilane
• CAS: 953076-21-6
• 化学式: C₂₇H₃₂N₄O₃SSi
• 分子量: 520.728
• InChiKey: DPCTUNALKOWFGC-QFIPXVFZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.65
• 重原子数：
  36
• 可旋转键数：
  10
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  95.4
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  [4-(cyclopropylsulfanyl)phenyl][6-methoxy-5-(trifluoromethyl)pyridin-2-yl]methanone 、 (S)-3-(1'-phenyl-1'H-tetrazole-5'-sulfanyl)-1-tert-butyldiphenylsilyloxy-2-methylpropane 以obtained in Reference Example 1-68的产率得到1-phenyl-5-[(tetrahydrofuran-3-ylmethyl)sulfonyl]-1H-tetrazole
  参考文献：
  名称：

  2-PYRIDONE COMPOUNDS

  摘要：

  一种由公式[1]表示的2-吡啶酮化合物：{其中，在公式[1]中，由A表示的环代表苯环或吡啶环，X表示以下公式[3]所表示的任何结构：V表示单键或低碳基亚烷基，W表示单键、醚键或低碳基亚烷基（其中低碳基亚烷基可以包含醚键）}，该化合物的互变异构体或立体异构体，其药学上可接受的盐或其溶剂化物是具有优良GK激活效果并且可用作药物的化合物。

  公开号：

  US20110237791A1
• 作为产物：
  描述：

  (R)-3-(tert-butyldiphenylsilyloxy)-2-methylpropan-1-ol 在 ammonium heptamolybdate 、 双氧水 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 乙醇 、 甲苯 为溶剂， 反应 11.0h， 生成 (S)-3-(1'-phenyl-1'H-tetrazole-5'-sulfanyl)-1-tert-butyldiphenylsilyloxy-2-methylpropane
  参考文献：
  名称：

  Natural product synthesis from (8aR)- and (8aS)-bicyclofarnesols: synthesis of (+)-wiedendiol A, (+)-norsesterterpene diene ester and (−)-subersic acid

  摘要：

  Both enantiomers (8aR)-7 and (8aS)-7 of bicyclofarnesol were synthesized from the enzymatic resolution products (1R,4aR,8aR)-1,2,3,4,4a,5,6,7,8,8a-decahydro-5,5,8a-trimethyl-2-oxo-trans-naphthalene-1-methanol-2-ethylene acetal (8aR)-5 (98% ee) and acetate of(1S,4aS, 8aS)-1,2,3,4,4a, 5,6,7,8,8a-decahydro-5,5,8a-trimethyl-2-oxo-trans-naphthalene-1-methanol-2-ethylene acetal (8aS)-6 (> 99% ee), respectively. The formal synthesis of (+)-wiedendiol 1 was achieved via a coupling reaction of an ate complex derived from 1,2,4-trimethoxybenzene with allyl bromide (8aS)-8 derived from (8aS)-7. The total synthesis of (+)-norsesterterpene diene ester 2 was achieved, based on the synthesis of (13E,10S)-alpha,beta-unsaturated aldehyde 12, derived from (8aS)-7, followed by the selective construction of the (3E,5E)-diene moiety including a C(2)-stereogenic centre in (+)-2. The total synthesis of (-)-subersic acid 3 was carried out based on a Stille coupling between allyl trifluoroacetate congener 25c, derived from (8aR)-7, corresponding to the diterpene part, and aryl stannane congener 26 in the presence of Pd catalyst and CuI as an additive. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2007.07.010

文献信息

• 2-PYRIDONE COMPOUNDS
  申请人：KAWAGUCHI Takanori

  公开号：US20110237791A1

  公开（公告）日：2011-09-29

  A 2-pyridone compound represented by the formula [1]: wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.

  一种由公式[1]表示的2-吡啶酮化合物：其中，在公式[1]中，由A表示的环代表苯环或吡啶环，X表示以下公式[3]所表示的任何结构：V表示单键或低碳基亚烷基，W表示单键、醚键或低碳基亚烷基（其中低碳基亚烷基可以包含醚键）}，该化合物的互变异构体或立体异构体，其药学上可接受的盐或其溶剂化物是具有优良GK激活效果并且可用作药物的化合物。
• Natural product synthesis from (8aR)- and (8aS)-bicyclofarnesols: synthesis of (+)-wiedendiol A, (+)-norsesterterpene diene ester and (−)-subersic acid
  作者：Yuusuke Arima、Masako Kinoshita、Hiroyuki Akita

  DOI：10.1016/j.tetasy.2007.07.010

  日期：2007.7

  Both enantiomers (8aR)-7 and (8aS)-7 of bicyclofarnesol were synthesized from the enzymatic resolution products (1R,4aR,8aR)-1,2,3,4,4a,5,6,7,8,8a-decahydro-5,5,8a-trimethyl-2-oxo-trans-naphthalene-1-methanol-2-ethylene acetal (8aR)-5 (98% ee) and acetate of(1S,4aS, 8aS)-1,2,3,4,4a, 5,6,7,8,8a-decahydro-5,5,8a-trimethyl-2-oxo-trans-naphthalene-1-methanol-2-ethylene acetal (8aS)-6 (> 99% ee), respectively. The formal synthesis of (+)-wiedendiol 1 was achieved via a coupling reaction of an ate complex derived from 1,2,4-trimethoxybenzene with allyl bromide (8aS)-8 derived from (8aS)-7. The total synthesis of (+)-norsesterterpene diene ester 2 was achieved, based on the synthesis of (13E,10S)-alpha,beta-unsaturated aldehyde 12, derived from (8aS)-7, followed by the selective construction of the (3E,5E)-diene moiety including a C(2)-stereogenic centre in (+)-2. The total synthesis of (-)-subersic acid 3 was carried out based on a Stille coupling between allyl trifluoroacetate congener 25c, derived from (8aR)-7, corresponding to the diterpene part, and aryl stannane congener 26 in the presence of Pd catalyst and CuI as an additive. (c) 2007 Elsevier Ltd. All rights reserved.
• 2-pyridone compounds
  申请人：Kawaguchi Takanori

  公开号：US08822503B2

  公开（公告）日：2014-09-02

  A 2-pyridone compound represented by the formula [1]: wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.

  式[1]所表示的2-吡啶酮化合物：在式[1]中，由A表示的环代表苯环或吡啶环，X表示下列式[3]所表示的任何结构：V代表单键或较低的烷基烯基，W代表单键、醚键或较低的烷基烯基（其中较低的烷基烯基可能包含醚键）}，该化合物的互变异构体或立体异构体、其药学上可接受的盐或其溶剂化物是一种具有极佳的GK激活作用并可用作药物的化合物。